Summary:
Local doctors are recruiting participants to enroll in a two-period clinical research study on an investigational drug for subjects with active psoriatic arthritis and have inadequate response to biologic disease modifying anti-rheumatic drugs (bDMARDs).
Qualified Participants Must:
Be 18 years old or older
Have been diagnosed with Psoriatic Arthritis (PsA) with symptoms for at least 6 months
Have been diagnosed with active plaque psoriasis or documented history of plaque psoriasis
Have inadequate response to or intolerance to treatment with at least 1 bDMARD
Qualified Participants May Receive:
Study-related medication and study-related care is provided at no cost to qualified participants. Qualified participants may be compensation for travel.